New drug trial targets Tough-to-Treat breast cancer

NCT ID NCT05573126

Summary

This study is testing a new drug called EP0062, both alone and combined with standard treatments, for women with a specific type of advanced breast cancer that has come back after prior therapy. The main goals are to find the safest and most effective dose and to see how well the drug works to control the cancer. It is for postmenopausal women whose cancer tests positive for certain hormone receptors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Henry Ford Hospital

    RECRUITING

    Detroit, Michigan, 48202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

  • Hospital 12 de Octubre

    RECRUITING

    Usera, Madrid, 28041, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitari Vall d'Hebron (VHIO)

    RECRUITING

    Barcelona, 08035, Spain

  • Hospital Universitario Ramón y Cajal

    RECRUITING

    Madrid, 28034, Spain

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-••••

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • NEXT Oncology Hospital Quironsalud

    RECRUITING

    Madrid, 28223, Spain

  • Sarah Cannon Research Institute

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sarah Cannon Research Institute UK

    RECRUITING

    London, Harley Saint, W1G 6AD, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Texas Oncology Baylor University Medical Center

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Christie NHS Foundation Trust

    RECRUITING

    Manchester, Wilmslow Rd, M20 4BX, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Clatterbridge Cancer Centre

    RECRUITING

    Liverpool, CH63 4JY, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yale School of Medicine

    RECRUITING

    New Haven, Connecticut, 06520, United States

Conditions

Explore the condition pages connected to this study.